Cocrystal Pharma, Inc. (COCP) Tops Q3 EPS by 12c

Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q3 EPS of ($0.41), $0.12 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Investing.com’s stocks of the week
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results